Eutropics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Angel

  • Investors
  • 2

Eutropics General Information

Description

Developer of a predictive diagnostic biomarker technology designed to predict patient response to specific chemotherapies. The company's technology specializes in advancing in vitro diagnostics tools and personalized medicine to diagnose and treat cancer and reduce unnecessary suffering, enabling physicians to detect cancerous cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • 767-C Concord Avenue
  • Cambridge, MA 02138
  • United States
+1 (617)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Diagnostic Equipment
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 767-C Concord Avenue
  • Cambridge, MA 02138
  • United States
+1 (617)

Eutropics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eutropics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 21-Aug-2024 Completed Generating Revenue
3. Angel (individual) 18-Nov-2021 Completed Generating Revenue
2. Grant 01-Jan-2017 $8.07M Completed Generating Revenue
1. Grant 01-Jan-2016 $800K Completed Generating Revenue
To view Eutropics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Eutropics Patents

Eutropics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240425583-A1 Methods and compositions related to mcl-1 and bim heterodimer antibodies Pending 26-Jul-2021
CA-3203105-A1 Methods and compositions related to bcl2 and bim heterodimer antibodies Pending 22-Dec-2020
US-20240043529-A1 Methods and compositions related to bcl2 and bim heterodimer antibodies Pending 22-Dec-2020
EP-3740757-A1 Methods for predicting cancer drug responsiveness Inactive 18-Jan-2018
US-20200348280-A1 Methods for predicting cancer drug responsiveness Pending 18-Jan-2018 A61P35/00
To view Eutropics’s complete patent history, request access »

Eutropics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eutropics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute Government
MassVentures Venture Capital Minority
To view Eutropics’s complete investors history, request access »

Eutropics FAQs

  • When was Eutropics founded?

    Eutropics was founded in 2005.

  • Where is Eutropics headquartered?

    Eutropics is headquartered in Cambridge, MA.

  • What is the size of Eutropics?

    Eutropics has 7 total employees.

  • What industry is Eutropics in?

    Eutropics’s primary industry is Biotechnology.

  • Is Eutropics a private or public company?

    Eutropics is a Private company.

  • What is Eutropics’s current revenue?

    The current revenue for Eutropics is .

  • How much funding has Eutropics raised over time?

    Eutropics has raised $350K.

  • Who are Eutropics’s investors?

    National Cancer Institute and MassVentures have invested in Eutropics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »